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Abstract
Macrofollicular variant papillary thyroid carcinoma (MFV-PTC) is deﬁned as papillary thyroid carcinoma with macrofollicles of >200m
m in more than 50% of the cross-sectional area of the specimen. The aim of this study was to evaluate the clinicopathologic
characteristics of the MFV-PTC treated in the Yonsei University College of Medicine.
Between September 2007 and July 2012, 18,697 patients with PTC were treated in our institution. Of these, 10 patients (0.05%)
were diagnosed as the MFV-PTC in ﬁnal pathologic report.
Mean age of 10 patients were 42.5 years old, ranging from 26 to 69 years. Twelve lesions were found in 10 patients. On
preoperative ultrasonographic examination, most of tumors looked like benign nodules. The tumor nodules varied in size from 0.3 to
3.5cm in greatest dimension. Microscopically, the macrofollicles were surrounded by cuboidal cells with hyperchromatic nuclei and
occupied entire nodule.
MFV-PTC showed the benign appearance in ultrasonography. To avoid misdiagnosis of MFV-PTC, clinicians should be aware of
the characteristics of MFV-PTC and perform ultrasonography with ﬁne needle aspiration biopsy appropriately.
Abbreviations: ATA = American Thyroid Association, CCND = central compartment node dissection, KTA = Korean Thyroid
Association, PTC = papillary thyroid carcinoma, PTC, MFV-PTC = macrofollicular variant.
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Macrofollicular variant is one of the variant of papillary thyroid
carcinoma (PTC), which was ﬁrst reported in 1991.[1] Macro-
follicular variant papillary thyroid carcinoma (MFV-PTC) is a
well-differentiated thyroid carcinoma with large, follicular
architecture and with nuclear characteristics of PTC including
enlarged, ground glass clear nuclei, and nuclear grooves.[2,3]
MFV-PTC is clinically important as it as a differential
diagnosis for a thyroid nodule. The differential diagnosis for
thyroid nodules include MFV-PTC and benign disease which
include goiter, macrofollicular adenoma, follicular neoplasm,
and hyperplastic nodule.[4,5]Editor: Eleonore Fröhlich.
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1The aim of this study was to evaluate the clinicopathologic
characteristics of the MFV-PTC treated in our institution.
2. Materials and methods
Between January 2007 and June 2012, of 18,697 patients with
PTC were treated in the Department of Surgery, Yonsei
University College of Medicine, Seoul, Korea. Around 10
patients (0.05%) were diagnosed as the MFV-PTC in ﬁnal
pathology report. In the same period, 926 patients (4.95%) were
diagnosed as the follicular variant papillary thyroid carcinoma.
Extent of thyroidectomy was performed based on the
American Thyroid Association (ATA) and Korean Thyroid
Association (KTA) guidelines.[6,7] Central compartment node
dissection (CCND) was performed in ipsilateral side routinely
and contralateral CCND was performed on patients with
suspicious metastatic node on contralateral side.
All pathology slides were reviewed and MFV-PTC was
conﬁrmed by the specialized pathologist (HSW). Demographic
feature of patients, preoperative ultrasonography, and ﬁnal
pathology results were reviewed retrospectively.
Approval to conduct a retrospective review of the images and
medical records of patients was obtained by the Institutional
Review Board of our institution (IRB No. 3-2012-0156). The
institutional review board approved this retrospective observa-
tional study and required neither patient approval nor informed
consent for the review of their records.
3. Results
The clinicopathologic characteristics of the patients are listed in
Table 1. There were 2men and 8women, with amean age of 42.5
± 13.6 years. The preoperative ultrasonographic ﬁndings of
MFV-PTC are summarized in Table 2.
Table 1
The clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma
∗
.
Patient
no. Gender Age
FNAB (Bethesda
classiﬁcation)
Frozen
pathology
Size,
cm Multiplicity Margin
Extrathyroidal
extension
Surgical
procedure
Lymph node
metastasis
RAI,
mCi
Disease free survival
duration, months
1 F 49 5 PTC 1.4 Single Expanding Yes Bilateral total thyroidectomy
with CCND
No 130 36
2 F 69 3 1.5 Multiple Expanding No Bilateral total thyroidectomy
with CCND
No 30 32
3 M 38 Rt.5/Lt.2 Rt. Lt. MFV-PTC Rt. 1.4
Lt. 1.1
Bilateral Expanding No Bilateral total thyroidectomy
with CCND
No 30 27
4 F 45 Rt.2/Lt.5 Lt. PTC Rt. 0.4
Lt. 0.8
Bilateral Expanding No Bilateral total thyroidectomy
with CCND
No No 2
5 F 42 0.3 Single No Completion total
thyroidectomy
with CCND
Central 3/4 30 50
6 F 32 5 Deferred 0.5 Single No Rt. hemithyroidectomy
with CCND
No No 50
7 M 37 3 1.5 Single No Rt. hemithyroidectomy
with CCND
No No 47
8 F 69 6 1.5 Multiple Expanding No Bilateral total thyroidectomy
with CCND
No 30 21
9 F 28 5 Favoring adenomatous
hyperplasia
3.5 Single Expanding No Rt. hemithyroidectomy
with CCND
No No 13
10 F 26 6 PTC 2.7 Single No Bilateral total thyroidectomy
with CCND
No 100 18
CCND=prophylatic central compartment node dissection, F= female, FNAB= ﬁne needle aspiration biopsy, M=male, MFV-PTC=macrofollicular variant of papillary thyroid carcinoma, PTC=papillary thyroid
carcinoma.
∗
Central lymph node metastasis was not originated from macrofollicular variant PTC but from papillary thyroid microcarcinoma of left hemithyroidectomy before 6 years ago.
Lee et al. Medicine (2018) 97:9 MedicineInternal content of MFV-PTC was predominantly solid,
ovoid to round lesions. None of the 12 cancer lesions had
suspicious malignant ﬁndings such as taller than wide shape,
ill-deﬁned margin, and microcalciﬁcation. On ultrasonogra-
phy, 4 of the tumors were hypoechoic, while the rest were
isoechoic.
Fine-needle aspiration cytology was performed in 11 of 12
tumors. Of these, 7 tumors were diagnosed as suspicious or
carcinoma (Bethesda category V or VI) and the other lesions were
benign and atypia (Bethesda category II or III). The tumor size
varied from 0.3 to 3.5cm (mean, 1.4±0.9cm).Table 2
The ultrasonographic characteristics of macrofollicular variant papill
Patient no 1 2 3 (Rt.) 3 (Lt.) 4 (R
Gender/Age F/49 F/59 M/38 M/38 F/4
Internal content
Predominantly solid >50% +  + + +
Predominantly cystic>50%  +   
Shape
Ovoid to round + + + + +
Taller than wide
∗     
Irregular     
Margin
Well-deﬁned smooth + + + + +
Well-deﬁned speculated     
Ill-deﬁned
∗     
Echotexture
Homogenous +  + + +
Heterogenous  +   
Echogenicity
Hypoechogenecity
∗     +
Isoechogenecity + + + + 
Hyperechoegecity     
Calciﬁcation
Microcalciﬁcation
∗     
Macrocalciﬁcation     
Rim calciﬁcation    + 
∗
Suspicious ﬁnding for malignant thyroid nodules on ultrasonography.
2Microscopically, macrofollicles and microfollicles were ob-
served synchronously and macrofollicles occupied almost the
entire nodule (Fig. 1A, C, and E). Most macrofollicle of tumors
were lined by cuboidal cell with irregular, ovoid and ground glass
nuclei (Fig. 1B, D, and F).
Central lymph node metastasis was found in one patient with
recurrent carcinoma. This patient was performed left hemi-
thyroidectomy at 6 years ago (patient 5, T1aN0M0 stage I). After
detection of recurrence in remnant thyroid gland, completion total
thyroidectomy with central compartment node dissection was
performed and the ﬁnal pathologic result showed one MFV-PTCary thyroid carcinoma.
t.) 4 (Lt.) 5 6 7 8 9 10
5 F/45 F/42 F/32 M/37 F/69 F/28 F/26
+ + + + + + +
      
+ + + + + + +
      
      
+ +  + + + +
      
      
+ +    + +
  + + +  
+ +  +   
  +  + + +
      
      
      
    +  
Figure 1. Histologic appearance of the tumor, which shows numerous macrofollicles>200mm with various sized follicles in thyroid (A, C, E; hematoxylin-eosin
stain 12.5), and shows ground glass appearance, hyperchromatin nuclei in lining cuboidal cell around of macrofollicles (B, D, E; hematoxylin-eosin stain 400).
(A, B—patient 3; C, D—patient 1; E, F—patient 2).
Lee et al. Medicine (2018) 97:9 www.md-journal.comon remnant thyroid gland and central lymph node metastasis (3 of
4) which might be originated from conventional PTC treated at
6 years ago.
On follow-up duration from 2 to 50 months (median 29.5
months), recurrence was not observed in all patients (Fig. 2).
4. Discussion
The MFV-PTC is a rare entity, which was ﬁrst reported
in 1991.[1] Albores-Saavedra et al[1] described 17 cases of
macrofollicular variant of an encapsulated papillary carcinoma
of the thyroid, which can be easily confused and misdiagnosed as
benign nodules.
The follicular-patterned lesions of the thyroid gland are a
spectrum of lesions spanning from hyperplastic nodules to
follicular variant of PTC and follicular thyroid carcinoma.
Follicular variant of PTC is characterized by follicular architec-
ture and cytomorphologic features of PTC. The follicles are small
in size and are associated with thick dense colloid.[2] MFV-PTC is
a well-differentiated thyroid carcinoma with large, follicular
architecture and with nuclear characteristics of papillary thyroid
carcinoma including enlarged, ground glass clear nuclei, and
nuclear grooves.[3] The major difference of macrofollicular
variant and follicular variant of PTC is the size of follicles. The3follicle size of follicular variant is 20–40mm, and that of
macrofollicular variant is various, predominantly macrofollicle
larger than 250mm.
Macrofollicles lined by cells with clear nuclei are found in
goiter and adenomas and in this variant of PTC. However, in
goiter and adenomas the nuclei are not enlarged and do not
overlap as they do in MFV-PTC.[3] According to the deﬁnition,
the PTCmust have macrofollicles of>200mm in more than 50%
of the cross-sectional area of the specimen to diagnose MFV-
PTC.[4,5] Because of its histologic features, the differential
diagnosis with benign diseases including goiter, follicular
adenoma, or hyperplastic nodule may be challenging.
Preoperative diagnosis of this variant is very difﬁcult.
Suspicious features for malignancy on thyroid ultrasonography
are taller than wide shape, speculated margin, marked hypo-
echogenicity, and the presence of calciﬁcation.[8–10] Ultrasono-
graphic ﬁndings ofMFV-PTC show the pattern of benign thyroid
nodules. They demonstrated ovoid to round, well-deﬁned smooth
margined, homogenous nodules (Table 2).
Fine-needle aspiration cytology is the main diagnostic method
for diagnosing the thyroid carcinoma, 7 of 11cases was diagnosed
by cytology in this study.[6,7] But preoperative cytology result also
confused between PTC and benign lesions. The left-sided tumor of
patient 3 and right-sided tumor of patient 4 were diagnosed as
Figure 2. Transverse ultrasound image of macrofollicular variant of PTC, which has well-deﬁned smooth margin, ovoid to round shape (A–D), and which shows
isoechogenic solid nodule (A) or hypoechogenic nodule (C), or mixed echogenic nodule (B, D). (A—patient 2; B—patient 3; C—patient 6; D—patient 9). PTC=
papillary thyroid carcinoma.
Lee et al. Medicine (2018) 97:9 Medicinebenign nodule in preoperative ﬁne-needle aspiration cytology.
MFV-PTC lesion of patients 3 and 5 were discovered accidentally
in the course of surgery for another cancer lesion. These cases were
not bewith ipsilateral or contralateral cancer lesion, theMFV-PTC
lesion is missed out and not operated.
Elastography is used in the evaluation of thyroid nodules for
distinguishing benign from malignant by comparing tissue
elasticity.[11] Strain and shear-wave elastography (SWE) are 2
types of elastography in clinical practice.[11,12] Two kinds of
elasticity can be assessed by strain elastography. First, colors
around and within the nodules were evaluated and visually
scored according to the 4–5-scale scoring systems. Second,
regions of interest are speciﬁed as the target region and the
adjacent reference region. Later, elastograph calculates strain
ratio automatically. Higher strain ratio leads to a high probability
of malignancy.[11,12]
Although elastography is beneﬁcial to distinguish benign and
malignant thyroid nodules, elastography was not used in the
present study. Due to this why our institution has set elastography
examination lately and radiologists in our institution were not
familiar to perform elastography in thyroid nodules.
In gross ﬁndings of the specimens, they also look like the
benign thyroid lesions. On frozen section the tumors, composed
predominantly of macrofollicular structures often lined with low
cuboidal or ﬂat cells with small, hyperchromatic nuclei, are likely
to be confused with goiter or macrofollicular adenoma.[3,13]
There have been few articles reporting the clinical presentation
and the prognosis ofMFV-PTC.[1,4,14] It has been described as an
indolent disease with a good prognosis and a moderate risk of
metastasis as compared with conventional PTC.[4] This is
probably due to the presence of a capsule, the well-differentiated
character of the neoplastic cells, and the low proliferative activity
of the tumor.
Limitations of this study are small cases and single institutional
experience. Generalizing to small cases and single institutional
experience can be a big mistake. Next step for us is to conﬁrm
these clinicopathologic characteristics of this rare variant of PTC.45. Conclusion
Although MFV-PTC is rare entity, with 0.06% of incidence at
our institution, the differential diagnosis on preoperative
evaluation modalities is important because of its benign
looking characteristics on ultrasonographic examinations.
Clinicians should be aware of the characteristics of MFV-PTC
and do not miss the possibility of MFV-PTC in preoperative
examinations.References
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